The United States is experiencing an opioid epidemic. Sadly, opioid-related fatalities are on the rise, causing profound emotional, financial, and cultural impacts. One way to reduce these negative impacts is to prevent people from developing opioid use problems in the first place. Research shows that youth and young adults in the juvenile justice system have higher rates of opioid use disorder than other young people in the general population. The POST Study seeks develop, implement and evaluate the effectiveness and cost of 2 opioid use prevention programs of varying intensities. The prevention programs are designed specifically for youth and young adults living in justice settings. It is implemented during the time they are transitioning out of incarceration and back into the community. The research team hopes their results will help justice settings implement their own effective opioid prevention programs in the future.
Age range
15 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of substance use episodes
Timeframe: Last 30 days at 2 months post-release (Phase I)
Number of substance use episodes
Timeframe: Last 30 days at 3 months post-release (Phase II)
Number of substance use episodes
Timeframe: Last 30 days at 6 months post-release (Phase II)
Frequency of substance use episodes
Timeframe: Last 30 days at 2 months post-release (Phase I)
Frequency of substance use episodes
Timeframe: Last 30 days at 3 months post-release (Phase II)
Frequency of substance use episodes
Timeframe: Last 30 days at 6 months post-release (Phase II)
Rate of Recidivism
Timeframe: 12 months post-release
Rate of Recidivism
Timeframe: 18 months post-release